Clinical Trial Update: Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the combination of adebrelimab and trametinib for refractory recurrent Langerhans cell histiocytosis in children and adolesc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Langerhans Cell Histiocytosis

Drugs mentioned

• Adebrelimab (adebrelimab)
• Trametinib (trametinib)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Histiocytosis, Langerhans-Cell | Phase 1 | Status: ENROLLING_BY_INVITATION